Oral supplement films using OPAU technology
Revolutionary OPAU technology creates nanofibrous oral supplement films for rapid or sustained delivery of active compounds. Ideal for paediatric and elderly patients, these films enhance dissolution rates and bioavailability while offering tailored delivery profiles.
Overview
OPAU technology introduces an innovative approach to oral supplements, moving beyond traditional tablets and capsules. This technology employs a film-based formulation composed of nanofibrous materials, creating a highly porous structure. The films can be customized for various delivery profiles, including ultra-fast dissolving orodispersible films for rapid micronutrient delivery and sustained-release adhesive films for controlled delivery. This flexibility allows for effective delivery of both water-soluble and oil-soluble compounds, making it especially beneficial for patients who struggle with standard solid dosage forms.
Technical specifications
Key features:
- Nanofibrous films: Create a porous structure ideal for encapsulating active compounds.
- Customizable delivery profiles: Tailored for ultra-fast or sustained-release applications.
- Versatile compound delivery: Suitable for both hydrophilic and hydrophobic active pharmaceutical ingredients.
- Enhanced dissolution rates: Improves bioavailability of poorly soluble pharmaceutical actives.
- Patient-friendly format: Particularly advantageous for paediatric and elderly patients.
Technology readiness level
Currently at Technology Readiness Level 3, OPAU technology has been successfully trialled for the controlled delivery of various pharmaceutical actives and is progressing through a structured proof-of-concept project. Further development and optimization are underway, focusing on formulation development, prototype optimization, and in vitro evaluation stages.
About University of East Anglia
The University of East Anglia (UEA) is a comprehensive public research university in Norwich, United Kingdom. The campus sits within a major research park alongside an NHS teaching hospital, enabling co‑located laboratories, clinical access, and regulated trials. Industry engagement includes placements, contract research, consultancy, and fast‑track agreements delivered through a central research and innovation office. Research is funded by UK Research and Innovation and its councils, the National Institute for Health and Care Research, and major charitable foundations. A dedicated technology transfer office manages IP, licensing, and spinouts, with on‑campus innovation space for partners.
delivered to your inbox.